Acne Drugs Market Growth, Demand and Challenges of the Key Industry Players By 2022-2027

Author: Elena Anderson

Marketing Manager

Report DescriptionAbout IMARC Group

International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Report Description Report Description and Highlights

Global Acne Drugs Market Research Report 2022-2027:

As per the latest report by IMARC Group, titled “ Acne Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-20 27,”

the global acne drugs market reached a value of US$ 6.1 Billion in 2021.

Acne is a dermatological condition that occurs when the hair follicles in the skin get clogged by sebum, dead skin cells and harmful bacteria. Although it is most common among teenagers, it can affect people of all ages. Factors like emotional stress, hot and humid climate and hormonal fluctuations during puberty can cause the onset of acne by enlarging oil glands under the skin. Acne drugs are used for treating bacterial infections or reduce oil production in the skin, which helps lower the occurrence of acne. These drugs include lifestyle remedies, topical and oral medicines, and medical procedures.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request for a PDF sample of this report: https://www.imarcgroup.com/acne-drugs-market/requestsample

Global Acne Drugs Market Trends:

Acne is one of the most prevalent skin diseases globally and is estimated to affect 9.4% of the population worldwide. Along with this, the increasing prevalence of skin-related diseases due to genetic factors or heavy cosmetics has led to a significant rise in the demand for acne drugs across the globe. Moreover, dermatologists and researchers are developing safer and more advanced treatment drugs with a better understanding of acne pathology.

For instance, Paratek and Allergen developed Sarecycline, an oral tetracycline-class drug, for which a tablet formulation is approved in the USA for the treatment of inflammatory lesions of non-modular moderate to severe acne vulgaris. Some of the other medications prescribed by dermatologists include topical retinoids, topical antibiotics, azelaic acid and antibiotic tablets, which are commonly used to treat moderate to severe acne.

Looking forward, the market is expected to grow at a CAGR of 7.4% during the forecast period (20222027)

View Report TOC, Figures and Tables: https://www.imarcgroup.com/acne-drugs-market

Report Description Report Description and Highlights

Key Market Segmentation

The research report includes the following segments:

Breakup by Acne Type

• Comedonal

• Inflammatory

• Cystic

• Postsurgical/Wound

Breakup by Drug Class:

• Retinoids

• Antibiotics

• Hormonal Agents

• Combination Drugs

• Others

Breakup by Drug Type:

• OTC Drugs

• Prescription Drugs

Breakup by Route of Administration:

• Topical

• Oral

• Injectable

Breakup by Region:

• North America

• Asia Pacific

• Europe

• Latin America

• Middle East and Africa

Competitive Landscape with Key Players:

• Allergan Plc

• Bausch Health Companies Inc.

• Bayer Aktiengesellschaft

• Cipher Pharmaceuticals Inc.

• Galderma Holding SA

• Johnson & Johnson

• Pfizer Inc.

• Reckitt Benckiser Group Plc

• Skinvisible Pharmaceuticals Inc.

• Sun Pharmaceutical Industries Limited

• Teva Pharmaceutical Industries Ltd.

1. How has the global acne drugs market performed so far and how will it perform in the coming years?

2. What has been the impact of COVID-19 on the global acne drugs market?

3. What are the key regional markets?

4. What is the breakup of the market based on the acne type?

5. What is the breakup of the market based on the drug class?

6. What is the breakup of the market based on the drug type?

7. What is the breakup of the market based on the route of administration?

8. What are the various stages in the value chain of the industry?

9. What are the key driving factors and challenges in the industry?

10. What is the structure of the global acne drugs market and who are the key players?

11. What is the degree of competition in the industry?

Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/acne-drugs-market/toc

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

A partial List of our Clients

Partial List of Clients

We are the trusted business partners to the world's leading corporates, governments, and institutions

Report Description Report Description and Highlights

© 2022 IMARC All Rights Reserved

This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC).

Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication.

IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.